AdreView, Iobenguane (I-123) Injection

7680525380257 CH-52538 Iobenguane (I-123) Injection
AdreView, Iobenguane (I-123) Injection
AdreView, Iobenguane (I-123) Injection
AdreView, Iobenguane (I-123) Injection
1 / 3
google

Article details

Package size
37
Selling units
37
Measure
MBq
Galenic form
Iobenguane (I-123) Injection
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
31/03/2022
Summary of Product Characteristics
Français
31/03/2022

Detailed composition

Substance Quantity Type Category
(N/A)
74.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.3 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
4.23 MG Substance HBESI

Reimbursement information

Public price
CHF 335.30
Specialties list
Yes
Generic
No
SL addition date: 01/06/1999

Authorization holder

medeo AG

5405 Baden

Authorization information

Swissmedic authorization number
52538
Drug name
AdreView, Injektionslösung (I-123), Injection
Galenic form
LSPA
ATC Code
V09IX01
Authorization status
Z
Dispensing category
A
First authorization
29/12/1994
Authorization expiration date
31/12/9999
IT Number
17.01.9.
Domain
Human medicine
Field of application
Tumorszintigraphie, Funktionsuntersuchung des Nebennierenmarks

Package details

Description (FR)
ADREVIEW Iobenguane (I-123) sol inj 37 MBq
Description (DE)
ADREVIEW Iobenguane (I-123) Inj Lös 37 MBq
Market launch
29/12/1994
Narcotic (BTM)
No

Other package sizes (10)

None
74 MBQ
GTIN: None
Not in V1
None
111 MBQ
GTIN: None
Not in V1
None
148 MBQ
GTIN: None
Not in V1
None
185 MBQ
GTIN: None
Not in V1
None
222 MBQ
GTIN: None
Not in V1
None
259 MBQ
GTIN: None
Not in V1
None
296 MBQ
GTIN: None
Not in V1
None
333 MBQ
GTIN: None
Not in V1
None
370 MBQ
GTIN: None
Not in V1
None
407 MBQ
GTIN: None
Not in V1